PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for June 6, 2006 Subscribe to this News Feed    Subscribe to this Podcast Feed
 

New Aroma Patch Restores Lost Libido in Women without Drugs or Side Effects

U.K.-based CST Medical Ltd. has released for sale in Canada and the U.S. the Scentuelle patch, a non-medical treatment for low libido that increases women’s sexual desire and that has already caught on in Europe and elsewhere (www.myscentuelle.com).

Toronto, ON (PressReleaseHelp/PRWEB ) June 6, 2006 -- According to published reports by American and Canadian scientists, up to 35% of women suffer from low libido and lack of sexual desire. Besides threatening relationships, this problem causes great personal distress in many women, affects their self-esteem and reduces their enjoyment of life. Pharmaceutical giants have spent hundreds of millions of dollars on so far fruitless efforts to develop a safe, effective counterpart of Viagra for women. Now, however, U.K.-based CST Medical Ltd. has released for sale in Canada and the U.S. the Scentuelle patch, a non-medical treatment for low libido that increases women’s sexual desire and that has already caught on in Europe and elsewhere (www.myscentuelle.com).

“Pharmaceutical companies by their very nature look for solutions that alter the body’s chemical composition,” says Liz Paul, president of CST Medical and recipient of the British Female Inventor of the Year Award for 2003. “The Scentuelle patch improves women’s libido from an entirely different angle – by targeting the brain’s smell receptors with aroma molecules that mimic dopamine, the body’s natural ‘feel-good’ hormone. Women wear a transparent patch containing our scientifically formulated aroma and sniff it once per hour. Nothing crosses the skin or enters the bloodstream, so it’s safe and without side effects.”

Scentuelle evolved from 18 months of research by CST Medical’s lead scientist, Dr. George Dodd, a Scottish biochemist whose research into the molecular chemistry of aromas has interested the U.K. Ministry of Defense, Unilever and Nokia, among other clients. The effects of Scentuelle’s aroma accumulate and build to its greatest level of effectiveness for the woman user over the course of three weeks.

Introduced in Spring 2005 in Europe, Scentuelle has sold more than 250,000 packages in the U.K. alone. The product is of particular value for menopausal or overstressed women, new mothers and others with reduced sexual drive who have simply “lost that loving feeling.”

A box of 30 Scentuelle aroma patches, enough for one month of daily use, costs $34.95 plus $4.00 shipping for delivery in the U.S. or Canada. The product arrives in discreet packaging. Orders may be placed online at www.myscentuelle.com or by phone to 1-888-412-1067 (toll-free). An extensive FAQ page at the web site answers more than 25 common questions about how the Scentuelle aroma patch works and how to use it.

For more information, contact:
Luke Vorstermans
Director, Media and Communications
The Orion Group Ltd.
Tel: 888 412-1067

# # #

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/Q3Jhcy1Qcm9mLUluc2UtRW1wdC1JbnNlLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


Other Releases by this Member
OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
Email this story to a colleague
CONTACT INFORMATION
Luke Vorstermans
The Orion Group Ltd.
888-412-1067
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.